| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 121.19M | 137.08M | 119.63M | 199.72M | 195.28M | 175.94M |
| Gross Profit | 47.73M | 65.07M | 42.00M | 115.66M | 99.65M | 50.55M |
| EBITDA | 99.32M | 143.38M | 973.69M | 76.21M | 101.97M | 69.81M |
| Net Income | -61.60M | -26.58M | 831.66M | -116.44M | -26.12M | -327.43M |
Balance Sheet | ||||||
| Total Assets | 594.73M | 606.00M | 519.34M | 590.12M | 565.31M | 505.42M |
| Cash, Cash Equivalents and Short-Term Investments | 147.35M | 150.42M | 161.71M | 233.58M | 165.25M | 78.58M |
| Total Debt | 665.65M | 571.37M | 471.75M | 1.40B | 1.29B | 1.19B |
| Total Liabilities | 798.86M | 698.48M | 585.01M | 1.53B | 1.39B | 1.27B |
| Stockholders Equity | -203.48M | -92.54M | -66.17M | -940.23M | -823.25M | -759.75M |
Cash Flow | ||||||
| Free Cash Flow | -3.76M | 535.00K | -19.48M | 87.43M | 108.58M | 56.47M |
| Operating Cash Flow | 15.41M | 33.08M | -2.22M | 102.20M | 117.42M | 82.75M |
| Investing Cash Flow | -14.50M | -26.47M | -28.08M | -15.78M | -19.78M | -40.10M |
| Financing Cash Flow | -8.50M | -17.71M | -41.62M | -17.48M | -10.86M | -58.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
52 Neutral | £7.47M | -4.18 | -14.83% | ― | ― | ― | |
51 Neutral | £12.82M | -3.85 | -4.96% | ― | -12.37% | 76.00% | |
47 Neutral | £9.94M | -1.04 | -7.46% | ― | ― | ― | |
46 Neutral | £3.30M | -0.04 | 42.95% | ― | -10.73% | 24.24% | |
| ― | £3.82M | -1.31 | -13.06% | 55.43% | 14.40% | 26.92% |